Sudafed PE Sinus + Allergy & Pain Relief Tablets
Price range: $18.02 through $31.04
Sudafed PE Sinus + Allergy & Pain Relief tablets uses for allergy and hay fever symptoms, sinus pain & headache relief and blocked or runny noses.
Suitable for: Allergy and hay fever symptoms, sinus pain & headache relief and blocked or runny noses.
- Description
- Brand
- Reviews (0)
Description
Sudafed PE Sinus + Allergy & Pain Relief tablets uses for allergy and hay fever symptoms, sinus pain & headache relief and blocked or runny noses.
Suitable for: Allergy and hay fever symptoms, sinus pain & headache relief and blocked or runny noses.
Brand
Sudafed
Only logged in customers who have purchased this product may leave a review.
Product Information
Ingredients
Direction
Adults and Children 12 years and over:
Take 2 tablets every 4-6 hours when necessary. Do not exceed 8 tablets in 24 hours.
When to stop: Adults after a few days. Children after 48 hours except on medical advice
Warnings
â for children under 12 years
â if you are hypersensitive to any of the ingredients
â if you are taking antidepressants
â if you have taken antihistamines.
Ask your doctor before use if you
- have any medical condition or are taking any other medicines or are a chronic alcohol abuser
- have high blood pressure
- have heart problems
- are pregnant or breastfeeding.
Caution - Keep out of reach of children
- If symptoms persist, worsen, or if new symptoms appear, stop use and see your doctor
- Discontinue use and see a dcotor at the first sign of a skin reaction or any other sign of hypersensitivity
- Phenylephrine may cause sleeplessness in some people
- Chlorphenamine may cause drowsiness. If affected do not drive or operate machinery
- Avoid alcohol
- Keep to the recommended dose. If an overdose is taken or suspected, ring the Poisons Information Centre (Australia 131126, New Zealand 0800 764 766) or go to a hospital straight away even if you feel well because of the risk of delayed serious liver damage.















Reviews
There are no reviews yet.